RAAS Cascade - The Pressure Crew

The RAAS is a hormonal cascade that regulates blood pressure and fluid balance. It is initiated by decreased renal perfusion or low sodium delivery to the distal tubule.
- Trigger: ↓ Blood pressure or ↓ Na⁺ detected by macula densa.
- Release: Juxtaglomerular (JG) cells in the kidney secrete Renin.
⭐ The primary site of Angiotensin-Converting Enzyme (ACE) activity is the capillary endothelium of the lungs.
- Angiotensin II is the main effector, causing potent vasoconstriction and stimulating Aldosterone secretion.
- Aldosterone acts on the distal nephron to increase Na⁺ and water reabsorption, raising blood volume.
Negative Feedback - Pumping the Brakes

Multiple overlapping mechanisms regulate the RAAS to prevent over-activation.
- Short-Loop Feedback: Angiotensin II directly inhibits renin secretion from the juxtaglomerular (JG) cells of the kidney. This is a direct, local inhibitory effect.
- Long-Loop Feedback: Systemic changes triggered by RAAS activation ultimately suppress it.
- ↑ Blood Pressure: Increased systemic arterial pressure, sensed by renal afferent arterioles, directly decreases renin release.
- ↑ Na+ Delivery: Aldosterone-driven Na+ retention increases Na+ load at the macula densa, which signals JG cells to ↓ renin (Tubuloglomerular feedback).
⭐ Atrial Natriuretic Peptide (ANP), released from atrial myocytes in response to stretch, is the main physiological antagonist of the RAAS.
Clinical Tie-ins - Meds & Mayhem
-
Pharmacological Intervention:
- ACE Inhibitors (-prils): Inhibit ACE, ↓ Ang II & aldosterone. Used for hypertension & heart failure.
- 📌 ACE inhibitors cause Cough, Angioedema, & Teratogenicity (Captopril's CAT).
- ARBs (-sartans): Selectively block AT1 receptors, preventing Ang II effects. No impact on bradykinin (no cough).
- Aldosterone Antagonists (Spironolactone): Block mineralocorticoid receptors. Useful for Conn's syndrome & advanced heart failure.
- ⚠️ All can cause hyperkalemia, a key side effect to monitor.
- ACE Inhibitors (-prils): Inhibit ACE, ↓ Ang II & aldosterone. Used for hypertension & heart failure.
-
Pathological States:
- Renal Artery Stenosis: Decreased renal perfusion chronically activates RAAS, leading to severe secondary hypertension.
- Conn's Syndrome: Primary hyperaldosteronism causes hypertension, hypokalemia, and metabolic alkalosis.
⭐ The characteristic dry cough associated with ACE inhibitors is due to the accumulation of bradykinin, which is normally degraded by ACE.
High‑Yield Points - ⚡ Biggest Takeaways
- High blood pressure is the primary long-loop feedback signal, suppressing renin release from the juxtaglomerular apparatus.
- Angiotensin II exerts direct short-loop negative feedback on JG cells to ↓ renin secretion.
- Aldosterone-mediated ↑ in Na+ and water retention raises blood volume, indirectly inhibiting renin.
- Atrial Natriuretic Peptide (ANP), released in response to atrial stretch, directly inhibits both renin and aldosterone secretion.
- ACE inhibitors & ARBs interrupt the feedback loop, causing a compensatory ↑ in plasma renin activity.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app